M Rebolj

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. pmc Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
    Matejka Rebolj
    Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 338:b1354. 2009
  2. doi request reprint False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition
    Matejka Rebolj
    Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014 København K, Denmark
    Eur J Cancer 47:255-61. 2011
  3. pmc Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening
    M Rebolj
    Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK 1014 København K, Denmark
    Br J Cancer 103:310-4. 2010
  4. ncbi request reprint Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 121:1529-35. 2007
  5. doi request reprint Primary HPV screening for cervical cancer prevention: results from European trials
    Elsebeth Lynge
    Institute of Public Health, University of Copenhagen, Denmark
    Nat Rev Clin Oncol 6:699-706. 2009
  6. doi request reprint What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review
    M E Frederiksen
    Department of Public Health, University of Copenhagen, Copenhagen, Denmark
    BJOG 119:7-19. 2012
  7. ncbi request reprint Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 120:806-12. 2007
  8. doi request reprint Impact of technology on cytology outcome in cervical cancer screening of young and older women
    J Rask
    Department of Public Health, University of Copenhagen, Copenhagen, Denmark
    Int J Cancer 134:2168-79. 2014
  9. pmc The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
    I M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Br J Cancer 100:1240-4. 2009
  10. doi request reprint No increased risk for cervical cancer after a broader definition of a negative Pap smear
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 123:2632-5. 2008

Collaborators

Detail Information

Publications11

  1. pmc Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
    Matejka Rebolj
    Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
    BMJ 338:b1354. 2009
    ..To determine the incidence of cervical cancer after several negative cervical smear tests at different ages...
  2. doi request reprint False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definition
    Matejka Rebolj
    Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014 København K, Denmark
    Eur J Cancer 47:255-61. 2011
    ..The aim of this paper was to illustrate how the narrow definition affected the measured adverse effects of HPV DNA screening compared with cytology screening...
  3. pmc Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening
    M Rebolj
    Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK 1014 København K, Denmark
    Br J Cancer 103:310-4. 2010
    ..We assessed the compliance and its impact on > or =CIN3 detection in all eight randomised controlled trials (RCT) with published baseline-round data...
  4. ncbi request reprint Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 121:1529-35. 2007
    ..Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing...
  5. doi request reprint Primary HPV screening for cervical cancer prevention: results from European trials
    Elsebeth Lynge
    Institute of Public Health, University of Copenhagen, Denmark
    Nat Rev Clin Oncol 6:699-706. 2009
    ....
  6. doi request reprint What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review
    M E Frederiksen
    Department of Public Health, University of Copenhagen, Copenhagen, Denmark
    BJOG 119:7-19. 2012
    ..Several available alternatives for the follow-up of low-grade abnormal screening tests have similar outcomes. In this situation, women's preferences have been proposed as a guide for management decisions...
  7. ncbi request reprint Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 120:806-12. 2007
    ..In conclusion, the 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening-induced negative side effects...
  8. doi request reprint Impact of technology on cytology outcome in cervical cancer screening of young and older women
    J Rask
    Department of Public Health, University of Copenhagen, Copenhagen, Denmark
    Int J Cancer 134:2168-79. 2014
    ..In the laboratory with unchanged technology no trends in abnormality proportions were observed. The impact of LBC implementation on cytological abnormality proportions varied considerably across age groups. ..
  9. pmc The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
    I M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Br J Cancer 100:1240-4. 2009
    ..The CERs of cancer screening programmes will clearly increase, with approximately 4000 euro. However, because of the favourable CER's, including unrelated healthcare costs will in general have limited policy implications...
  10. doi request reprint No increased risk for cervical cancer after a broader definition of a negative Pap smear
    Matejka Rebolj
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 123:2632-5. 2008
    ....
  11. ncbi request reprint Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands
    Anita B Bos
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 119:2372-5. 2006
    ..We conclude that increasing screening participation has much more potential for further reducing cervical cancer incidence than reducing the screening interval, increasing the age range or having a screening test with higher sensitivity...